A phase I metabolic study of ALKS 3831 in healthy subjects
Latest Information Update: 12 Oct 2016
At a glance
- Drugs Olanzapine/samidorphan (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics; Pharmacokinetics
- 12 Oct 2016 New trial record
- 04 Oct 2016 Results from this study are expected in the first half of 2017, according to an Alkermes plc media release.